Reduced subcutaneous injections, fewer blood glucose checks, and dose-adjusted insulin at mealtimes may offer improved quality of life and increase adherence compared with traditional diabetes treatment regimens.71 Although injection site pain was uncommonly reported,63,71 oral formulations of GLP-1RA may still be preferred despite scarce evidence demonstrating CV benefit. Here, INS is linked to diabetes mellitus.